Development of biomarkers for multiple sclerosis as a neurodegenerative disorder
Authors:
- Ulf ZiemannUZUlf Ziemann
- Mathias WahlMWMathias Wahl
- Elke HattingenEHElke Hattingen
- Hayrettin TumaniHTHayrettin Tumani
- 1 December 2011
- journal article
- review article
- Published by Elsevier in Progress in Neurobiology
- Vol. 95 (4) , 670-685
Abstract
No abstract availableKeywords
This publication has 249 references indexed in Scilit:
- Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteriaAnnals of Neurology, 2011
- Neurodegeneration in autoimmune CNS inflammationExperimental Neurology, 2010
- Functional Alterations in Memory Networks in Early Alzheimer’s DiseaseNeuroMolecular Medicine, 2010
- Cerebrospinal fluid biomarkers in multiple sclerosisNeurobiology of Disease, 2009
- Multiple sclerosisThe Lancet, 2008
- Axonal loss and myelin in early ON loss in postacute optic neuritisAnnals of Neurology, 2008
- Reproducibility over a 1-month period of 1H-MR spectroscopic imaging NAA/Cr ratios in clinically stable multiple sclerosis patientsEuropean Radiology, 2008
- Altered diffusion tensor in multiple sclerosis normal‐appearing brain tissue: Cortical diffusion changes seem related to clinical deteriorationJournal of Magnetic Resonance Imaging, 2006
- Diffusion tensor imaging: Concepts and applicationsJournal of Magnetic Resonance Imaging, 2001
- Magnetization transfer changes in the normal appering white matter precede the appearance of enhancing lesions in patients with multiple sclerosisAnnals of Neurology, 1998